Prognostické faktory
Apoptóza
Extrinsic pathway
- Death receptors (DRs)
- Death-induced signaling complex (DISC)
- Aktivace caspase-8
- Cleaves Bid into truncated Bid (tBid)
- Translocating from the cytosol to the mitochondria [65]
Intrinsic pathway
Loss of mitochondrial membrane potential (MMP, ??m)
- Release of cytochrome c
- Activates caspase-9
- Caspases that cleave different substrates
- Dismantling of the cell [65]
Endoplasmic reticulum stress
Autophagy
- Conserved cellular degradation pathway
- For long-lived proteins and organelles [65]
- Induction of autophagy might maintain cancer survival under metabolic stress
- Mediate resistance to anticancer therapies [65]
- Inhibition of autophagy
- Enhances cancer cell death [65]
- Potentiates various anticancer therapies
- High levels of autophagy [65]
- Can induce a form of cell death known as type II cell death = autophagic cell death [65]
- Several cellular signaling pathways play a role in regulating autophagy
- Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) [65]
- Inhibiting Akt and its downstream target mTOR
- Contribute to the initiation of autophagy
- Initial stages of autophagy cellular proteins, organelles, and the cytoplasm [65]
- Autophagosomes
- Microtubule-associated protein 1 light chain 3 (LC3)
- Conjugated to phosphatidylethanolamine to form LC3-II [65]
- Recruited to autophagosomal membranes [65]
- Mature by fusing with lysosomes to form the autolysosomes
- Sequestered proteins and organelles are digested by lysosomal hydrolases [65]
- Recycled to sustain cellular metabolism [65]
- P62 was identified as an LC3-interacting protein [65]
- LC3- II present in the inner membrane of the autophagosome is degraded together with other cellular constituents by lysosomal proteases
- P62 trapped by LC3 is transported selectively into the autophagosome [65]
- The p62 protein localizes to sites of autophagosome formation
- Can associate with both the LC3 and ubiquitinated proteins
- P62 is considered to act as a receptor for ubiquitinated proteins, which it sequesters into the autophagosome
- Impaired autophagy is accompanied by accumulation of p62 [65]
Reactive oxygen species (ROS) [65]
- Formed by the incomplete reduction of oxygen
- Superoxide anion (O2-) [65]
- hydrogen peroxide (H2O2)
- Hydroxyl radicals (HO•)
- Intracellular redox homeostasis is a key determinant of cell fate
- Excessive ROS production usually results in cytotoxic effects [65]
- Might lead to apoptotic cell death
- Moderate levels of ROS function as second messengers
- Regulate diverse cellular processes such as cell survival, proliferation, and metastasis [65]
- Accumulation of ROS can induce autophagy,
- Facilitates the clearance of excessive ROS to protect cells from oxidative damage [65]
- ROS-mediated KEAP1 inhibition
Prognostické faktory nádorů žaludku
- Tumor growth is determined by
- The balance between proliferation and the apoptisis of tu mor cells
Antigens associated with proliferation
- Ki-67
- High proliferative activity have a worse prognosis [31]
- Pcna [31]
Circulating tumor cells (CTC)
- Presence of CTC is a major predictor of outcome in patients with gastric and gastroesophageal malignancies [6]
Hoxd10
- Was highly expressed in gastric cancer
- Correlated with size of tumor, Lauren classification, depth of invasion, lymph node and distant metastasis, Tumor-Node-Metastasis (TNM) stage, and prognosis [7]
HOXB7
- Knockdown in BGC-823 and SGC-7901 resulted in
- Decreased migration and invasion [95]
- Alteration of epithelial-mesenchymal transition (EMT) proteins [95]
- Influenced proliferation, apoptosis, and cell cycle [95]
Expression of the enhancer of zeste homolog 2 (EZH2)
- A histone methyltransferase
- Correlated with poor prognosis in human gastric cancer [28]
trimethylation of H3K9
- Is positively correlated with tumor stage, lymphovascular invasion, cancer recurrence [28]
High expression of Sirt7
- Predicts poor survival [28]
- Sirt7 knockdown reduces gastric cancer growth in vitro and in vivo
- Mechanically, Sirt7 prevents apoptosis of gastric cancer cells
- Epigenetically silencing miR-34a via deacetylating H3K18ac [28]
bcl-2
- The positivity of bcl-2 was higher in metaplasia and probably is involved in the progression of carcinogenesis [29]
- Bcl-2 expression was more frequent in the early than in the advanced stages of the disease [31]
- More frequently expressed in the intestinal compared with the diffuse type [31]
- Importance of Bcl-2 in gastric carcinogenesis, especially during its early stages [31]
- Bcl-2 with cell cycle progression [31]
- Initially been detected in human B-cell lymphoma cells [57]
- A member of a protein family which has important tasks in the apoptotic mechanisms [57]
- Bcl-2 inhibits apoptosis [57]
- Doesn’t increase cell proliferation
- Provides survival advantage to the rapidly proliferating cells due to DNA damages
- In most cancer types, it is less related to aggressive cancer progression
- In non-small cell lung cancer, breast cancer, ovarian cancer, soft tissue sarcoma and colon cancer
- Increased Bcl-2 expression was a good prognostic factor [57]
- In some cancer types
- Adverse prognostic factor [57]
- Prostate cancer
- Increased Bcl-2 expression
- Associated with resistance to hormonal treatment and recurrence [57]
- Breast cancer
- Associated with dismal prognosis [57]
- Bcl-2 protein blocks the accumulation of calcium ion in the nucleus in cells exposed to tumor necrosis factor or thapsigargin [61]
p53
- Was negative in metaplasia and positive in more than half of the gastric cancer
- Mostly in stage IV, suggesting a late event in gastric cancer [29]
- Increased expression of p53 protein was observed in the adenocarcinomas (43.1%) [31]
- Compared with the adjacent normal mucosa (2.4%) [31]
- Positive correlation was noted between p53 protein expression and
- Tumor size,
- Histological classification and
- protein Ki-67 immunoexpression [31]
- In adenocarcinomas, p53 is unable to correct dnadamage
- Thus blocking apoptosis
- Allowing the proliferation of cells with dnadamage [31]
- Ineffectiveness of p53 in controlling the proliferation of cells with dna damage [31]
- The tumor protein p53 (TP53) acts by stopping the cell cycle and starting induction of apoptosis. In more than 50% of malignancies mutated p53 has been shown [57]
- In DNA-damaged cells, p53 stops the cell cycle at the transition from the G1 to the S phase
- DNA-damaged cells cannot proliferate
- Are removed by aptotic processes [57]
- Mutated DNA-damaged cells which express p53 continue to proliferate. In normal cells, p53 is expressed at levels which cannot be easily detected by immunohistochemistry
- P53 is located on the short arm of chromosome 17, and mutated p53 is formed as a result of various point mutations and deletions.
- The mutant p53 can be highly expressed in tumor cells [57]
Bcl-x
- Immunoexpression in 88% of gastric adenocarcinomas [31]
- Bcl-xl was also found to slow the apoptotic effect of chemotherapy on tumor cells [31]
- Increased expression of Bcl-x
- Helps to inhibit apoptosis
- Triggering the uncontrolled proliferation of tumor cells [31]
Bak
- Increased expression of Bak
- Sensitizes tumor cells to low doses of 5-Fu and cisplatin [31]
- Enhances apoptosis by binding to Bcl-xl and inhibiting its anti-apoptotic effect
- Increased expression of Bak and Bad
- Was observed in the adjacent mucosa [31]
- Low expression of Bak and Bad
- Was found in the adenocarcinomas [31]
Bax
- Reduced expression
- Negative prognostic factor in patients with cancer of the
- Breast, ovary, colon, esophagus and pancreas [31]
- Loss of Bax expression
- In acute lymphoblastic leukemia in children
- Associated with resistance to chemotherapy
- Inappropriate activation of the caspase cascade [31]
- Bax overexpression
- Sensitizes cells to chemotherapeutic agent-induced apoptosis
- Enhancing release of cytochrome c from mitochondria
- Cytochrome c released into the cytosol forms a complex with another molecule, Apaf-1, and the unprocessed proform of caspase-9
- In the presence of dATP or ATP this complex activates the caspases
- Trigger a cascade by activating caspases-3, -6, and -7
- Several potential chemopreventive agents also exert their effect through bax and bak
- Overexpression of bax and bak
- Involved in apoptosis induced by aspirin and indomethacin
- Without altering bcl-2 and bcl-xL expression
mTOR
- The mammalian target of rapamycin
- Serine/threonine downstream mediator in phosphatidylinositol 3-kinase signaling pathway
- Could directly phosphorylate the translational regulator eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 and S6 kinase (p70S6K)13
- MTOR signaling pathway
- Regulate proliferation, growth, survival and mobility [53]
- Targets of the mTOR kinase, as well as the proteins regulating mTOR [53]
- Often been activated or mutated in many types of cancer [53]
- Overexpression of phospho-mTOR
- Independent prognostic factor of human gastric cancer
- Inhibiting the activation of mTOR axis signaling
- Attractive cancer therapeutic strategy [53]
Cyclophilin A (CypA)
- Candidate target protein in gastric carcinoma
- Elevated expression of CypA in GC tissues compared with normal gastric mucosa was observed [96]
- Especially in TNM stage-I and intestinal type of tumor [96]
- Overexpressed in most GC cell lines
- Endogenous expression of CypA correlated with cell growth phenotypes [96]
- Suppression of CypA reduced the proliferation of BGC-823 and SGC-7901 GC cell lines [96]
- Exogenous CypA promoted the proliferation of NCI-N87 GC cells in a concentration dependent manner [96]
Androgen receptor (AR) activation
- AR promotes gastric cancer cell migration and invasion [98]
- Via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9 [98]
- Important role in many kinds of cancers [98]
- AR expression was positively correlated with lymph node metastasis and late TNM stages [98]
- Activation of AKT [98]
- Upregulation of matrix metalloproteinase 9 (MMP9)
- AR overexpression
- Induced increases in GC cell migration, invasion and proliferation
- Attenuated by inhibition of AKT, AR and MMP9
- Upregulated MMP9 protein levels - counteracted by AR siRNA [98]
EGFR
- Was found highly expressed in cancer tissues
- Correlated with lymph node metastases
- Knockdown of EGFR
- Reduced [97]
- Cell proliferation [97]
- Invasion of GC [97]
- Expression of AKT, PCNA and MMP-9 [97]
- Induced [97]
- Cell apoptosis [97]
- Cycle arrest [97]
- Upregulation of EGFR expression is associated [97]
- Lymph node metastases of GC [97]
- Blockade of EGFR signaling suppresses [97]
- Growth [97]
- Invasion of GC cells through AKT pathway [97]
- EGFR may represent a potential therapeutic target for this aggressive malignancy [97]
Rezistence k chemoterapii
Mutations in the p53 gene
Overexpression of bcl-2 and/or bcl-xL
- 72% overexpress bcl-2
- Inhibition of apoptosis through bcl-2 protein [62]
- Specifically associated with promotion of intestinal-type gastric adenocarcinoma
- Bcl-2 overexpression
- Strongly blocks apoptosis by inhibiting
- Cytochrome c release from mitochondria
- Caspase-3 activation
Down-regulation or mutations of bax or bak [62]
- Bax frameshift mutations 33–40% of gastric cancers [62]
- High level microsatellite instability [62]
- Missense Bak gene mutations in 12.5% of gastric cancers [62]
- Sequence alterations without amino acid alteration in 4.2% of gastric cancers
MicroRNA (miRNA)
- Modulates the expression of a great number of genes
- including MDR
- +expression of miR-1284 was reduced in gastric cancer [93]
- With metastasis [93]
- In vincristine-resistant (VCR) GC SGC7901 cells (SGC-7901/VCR)
- Recombinant lentiviral vectors with miR-1284 led to the overexpression of miR-1284 mRNA [93]
- Reversed the chemoresistance of SGC7901/VCR cells
- Promoted cell cycle arrested at the G0/G1 phase [93]
- Accelerated drug-induced apoptosis
- Decreased migration and invasiveness of SGC-7901/VCR [93]
- Sensitized tumors to chemotherapy in vivo
- MiR-1284
- Can heighten the expression of MYC [93]
- Reduce the expression of JUN, MMP12, and EIF4A1
- Can function as a new regulator to reduce GC MDR cells by targeting EIF4A1 [93]
Markery
- Butanoic acid
- Butanoic acid 10.9 µmol / L or more [1]
- Hexanoic acids
- 15.9 µmol / L or less [1]
Literatura:
[1] Patent WO2010016558A1 - Disease marker, and method for measurement of disease marker - Patenty Google [Internet]. [citován 31. květen 2013]. Dostupné od: www.google.com/patents/WO2010016558A1?cl=en&hl=cs&dq=%2215454-75-8%22+OR+%225-oxoproline%22+OR+%22proline,+5-oxo-%22+OR+%225-Carboxy-2-pyrrolidinone%22+OR+%225-Oxo-2-pyrrolidincarbons%C3%A4ure%22+OR+%222-Pyrrolidone-5-carboxylic+acid+%22+OR+%225-OXO-2-PYRROLIDINECARBOXYLIC+ACID%22&source=uds
Immune-Cell Infiltration
- Significance of Immune-Cell Infiltration in Gastric]
- Tanaka H et al, Gan To Ganaka Ho Ryuhu 2018
- ”bylo prokázáno, že CD8+ T buňky reagují v u pokročilého karcinomu žaludku antigen-specifickým způsobem
- Možnost, že paměťové T-buňky, NK-buňky a NKT buňky v tkáních žaludečního karcinomu korelují s dobrou prognózou
- Přítomnost folikulárních lymfoidních struktur, nazývaných „terciární lymfoidní struktura“ (TLS), ve tkáních žaludečního karcinomu souvisí s lepší prognózu pacientů“...